ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Evidence-Based Medicine Comes to Otolaryngology

by Marlene Piturro, PhD, MBA • February 1, 2007

  • Tweet
  • Email
Print-Friendly Version

Not long ago, physicians routinely decried evidence-based medicine (EBM) as an encroachment on their professional autonomy, a barrier to good patient care, insensitive to health care’s growing complexity, and at odds with the transcendent value of the physician-patient relationship. Those objections have been swept away by the 21st century’s tidal wave of health care change-the quality improvement movement, pay-for-performance initiatives, and adoption of information technology. The 109th Congress’ last-minute passage of legislation that boosts reimbursement to physicians who report data on the quality of care they deliver is a huge step to tying EBM to reimbursement. Legislators may take further steps. They are using guidelines to pinpoint and, eventually, eliminate regional variations in medical treatments; to reduce spending on expensive ineffective therapies; and to encourage physicians to use evidence-based low-cost treatments rather than high-tech ones without mountains of EBM behind them. In short, EBM isn’t going away.

You Might Also Like

  • Evidence-Based Medicine: Adjusting to a Culture Shift in Health Care
  • Evidence-Based Research: The Foundation for Treatment Decisions
  • A New Direction for Sleep: New OSA guidelines fuel another evidence-based medicine debate
  • Allergy Research Gets High Evidence-Based Medicine Rankings
Explore This Issue
February 2007

Evidence-based medicine-the conscientious, explicit, and judicious use of current best data in making decisions about patient care-is here to stay. Payers are determined to align financial rewards to better clinical outcomes, which are defined through evidence-based guidelines. It sounds simple; it isn’t.

Most medical specialties, including otolaryngology, lag behind internal medicine in developing evidence-based medical guidelines. It isn’t because EBM is less important to specialties than to primary care medicine, only that each specialty consumes less of the health care spending pie than do primary medicine’s diagnoses. Understandably, public and private payers have pursued the most commonly diagnosed conditions that consume, in the aggregate, a proportionally larger amount of available resources-the low-hanging fruit.

By that logic, the key areas chosen by the Centers for Medicaid and Medicare Services (CMS) for pay-for-performance measures based on EBM account for 33% of hospital admissions and 20% of total claims paid. Those core measures, on which hospitals can now earn an additional 5% Medicare reimbursement for top-tier performance, relate to coronary artery bypass graft, acute myocardial infarction, community-acquired pneumonia, and heart failure. Conversely, hospitals performing poorly on the core measures lose 5% of Medicare payment.

A Different Perch

Medical specialties see EBM from a different vantage point than primary care physicians, who already have some pay tied to performance. With few payer incentives (yet) to develop guidelines, perhaps specialists have been hoping that the health care system’s focus on EBM would wane and pass them by, unscathed. Not so, according to David Nielsen, MD, CEO of the American Academy of Otolaryngology-Head and Neck Surgery Foundation. He said, We really can’t make excuses about not developing our own EBM. Because of the Cochrane Collaboration [see box] and other groups that focus on quality measures in medicine, we knew this was coming. We wrote consensus-based guidelines and that satisfied most practitioners, but it’s time for evidence-based medicine in our specialty.

Pages: 1 2 3 4 | Single Page

Filed Under: Articles, Clinical, Cover Article, Features Issue: February 2007

You Might Also Like:

  • Evidence-Based Medicine: Adjusting to a Culture Shift in Health Care
  • Evidence-Based Research: The Foundation for Treatment Decisions
  • A New Direction for Sleep: New OSA guidelines fuel another evidence-based medicine debate
  • Allergy Research Gets High Evidence-Based Medicine Rankings

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.